Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-002801

Chief Commercial Officer sold 15,625 shares at $75.00 ($1,171,875)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Hassard James Chief Commercial Officer 2021-01-07 Sale −15,625 $75.00 $1,171,875 109,375 D
Open-market sales · 15,625 sh · avg $75.00 · $1,171,875
Loading xslF345X03/doc4.xml…